1-苄基环丁胺 | 91245-60-2

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 1-苄基环丁胺
• 中文别名: (Z)-N-(2-羟基乙基)-N-[2-[[2-[(2-羟基乙基)氨基]乙基]氨基]乙基]-9-十八碳烯酰胺
• 英文名称: 1-Amino-1-benzyl-cyclobutan
• 英文别名: 1-Benzylcyclobutanamine；1-benzylcyclobutan-1-amine
• CAS: 91245-60-2
• 化学式: C₁₁H₁₅N
• mdl: MFCD09888625
• 分子量: 161.247
• InChiKey: VDTOJIIWQIMYNV-UHFFFAOYSA-N

物化性质

• 沸点：
  244.8±9.0 °C(Predicted)
• 密度：
  1.038±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.454
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-(2-bromoacetyl)-pyrrolidine-2,5-cis-dicarbonitrile 、 1-苄基环丁胺 以 乙腈 为溶剂， 反应 48.0h， 生成 (2R,5S)-1-(2-(1-benzylcyclobutylamino)acetyl)pyrrolidine-2,5-dicarbonitrile
  参考文献：
  名称：

  cis-2,5-Dicyanopyrrolidine Inhibitors of Dipeptidyl Peptidase IV:  Synthesis and in Vitro, in Vivo, and X-ray Crystallographic Characterization

  摘要：

  Inhibitors of the glucagon-like peptide-1 (GLP-1) degrading enzyme dipeptidyl peptidase IV (DPP-IV) have been shown to be effective treatments for type 2 diabetes in animal models and in human subjects. A novel series of cis-2,5-dicyanopyrrolidine alpha-amino amides were synthesized and evaluated as inhibitors of dipeptidyl peptidase IV (DPP-IV) for the treatment of type 2 diabetes. 1-({[1-(Hydroxymethyl) cyclopentyl] amino}acetyl) pyrrolidine-2,5-cis-dicarbonitrile (1c) is an achiral, slow-binding (time-dependent) inhibitor of DPP-IV that is selective for DPP-IV over other DPP isozymes and proline specific serine proteases, and which has oral bioavailability in preclinical species and in vivo efficacy in animal models. The mode of binding of the cis-2,5-dicyanopyrrolidine moiety was determined by X-ray crystallography. The hydrochloride salt of 1c was further profiled for development as a potential new treatment for type 2 diabetes.

  DOI：

  10.1021/jm0600085
• 作为产物：
  描述：

  l,3-bis(1-benzylcyclobutyl)urea 在 potassium carbonate 作用下， 以 乙二醇 为溶剂， 生成 1-苄基环丁胺
  参考文献：
  名称：

  [EN] (ALPHA-SUBSTITUTED CYCLOALKYLAMINO AND HETEROCYCLYLAMINO) PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE IN TREATING PROLIFERATIVE DISEASES
  [FR] (CYCLOALKYLAMINO OU HÉTÉROCYCLYLAMINO ALPHA-SUBSTITUÉ) PYRIMIDINYL ET 1,3,5-TRIAZINYL BENZIMIDAZOLES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT ET LEUR UTILISATION DANS LE TRAITEMENT DES MALADIES PROLIFÉRATIVES

  摘要：

  本文提供了（α-取代环烷基氨基或杂环烷基氨基）嘧啶基和1,3,5-三嗪基苯并咪唑类化合物，例如，Formula I的化合物，以及它们的药物组合物、制备和用作治疗增殖性疾病的药物或药剂。

  公开号：

  WO2012135175A1

文献信息

• [EN] CYCLOBUTENEDIONE DERIVATIVES<br/>[FR] DÉRIVÉS DE CYCLOBUTÈNE-DIONE
  申请人：PFIZER LTD

  公开号：WO2010131145A1

  公开（公告）日：2010-11-18

  The present invention relates to compounds of the formula (I): to pharmaceutically acceptable salts therefore and to pharmaceutically acceptable solvates of said compounds and salts, wherein the substituents are defined herein; to compositions containing such compounds; and to the uses of such compounds in the treatment of various diseases, particularly inflammatory conditions.

  本发明涉及以下式(I)的化合物：以及其药学上可接受的盐和所述化合物及盐的药学上可接受的溶剂化物，其中取代基在此处定义；含有这种化合物的组合物；以及这种化合物在治疗各种疾病，特别是炎症性疾病中的用途。
• Fluorine-Containing Compound, Fluorine-Containing Polymer Compound, Resist Composition and Patterning Method Using Same
  申请人：Mori Kazunori

  公开号：US20110318542A1

  公开（公告）日：2011-12-29

  There is disclosed a fluorine-containing polymer compound comprising a repeating unit (a) of the following general formula (2) and having a weight-average molecular weight of 1000 to 1000000 where R 1 represents a polymerizable double bond-containing group; R 2 represents a fluorine atom or a fluorine-containing alkyl group; R 3 represents a hydrogen atom, an acid labile group, a cross-linking site or the other monovalent organic group; and W 1 represents a linking moiety. When the fluorine-containing polymer compound is used in a resist compound for pattern formation by high energy radiation of 300 nm or less wavelength or electron beam radiation, it is possible to form a resist pattern with a good rectangular profile.

  本发明公开了一种含氟聚合物化合物，其包括下述通式（2）的重复单元（a），并且具有1000至1000000的重均分子量，其中R1表示聚合双键含有基团；R2表示氟原子或含氟烷基；R3表示氢原子、酸敏基团、交联位点或其他一价有机基团；W1表示连接基。当将该含氟聚合物化合物用于300纳米或更短波长的高能辐射或电子束辐射的图案形成的光阻化合物中时，可以形成具有良好矩形轮廓的光阻图案。
• (ALPHA-SUBSTITUTED CYCLOALKYLAMINO AND HETEROCYCLYLAMINO) PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE IN TREATING PROLIFERATIVE DISEASES
  申请人：MEI PHARMA, INC.

  公开号：US20140088102A1

  公开（公告）日：2014-03-27

  Provided herein are (alpha-substituted cycloalkylamino or heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, e.g., a compound of Formula I, and their pharmaceutical compositions, preparation, and use as agents or drugs for treating proliferative diseases.

  本文提供了(α-取代的环烷基氨基或杂环基氨基)嘧啶基和1,3,5-三嗪基苯并咪唑，例如式I的化合物，以及它们的制备、药物组成和用作治疗增生性疾病的药物或药剂的用途。
• PYRIMIDINE DERIVATIVES AS ION CHANNEL MODULATORS AND METHODS OF USE
  申请人：VERTEX PHARMACEUTICALS INCORPORATED

  公开号：EP1809290A2

  公开（公告）日：2007-07-25
• [EN] ION CHANNEL MODULATORS AND METHODS OF USE<br/>[FR] MODULATEURS DE CANAUX IONIQUES ET LEURS METHODES D'UTILISATION
  申请人：VERTEX PHARMA

  公开号：WO2006050476A2

  公开（公告）日：2006-05-11

  [EN] In general, the invention relates to compounds useful as ion channel modulators. It has now been found that compounds of this invention, and pharmaceutically acceptable compositions thereof, are useful as inhibitors of voltage-gated sodium channels and/or calcium channels.
  [FR] L'invention concerne en général des composés utilisés comme modulateurs de canaux ioniques. On a découvert que les composés de l'invention et des compositions de ceux-ci pharmaceutiquement acceptables sont utilisés comme inhibiteurs des canaux sodiques voltage-dépendants et/ou des canaux calciques.